| (Values in U.S. Thousands) | Apr, 2026 | Jan, 2026 | Jan, 2025 | Jan, 2025 | Apr, 2024 |
| Sales | 837,000 | 790,000 | 687,000 | 0 | 0 |
| Sales Growth | +5.95% | +14.99% | unch | unch | unch |
| Net Income | -183,000 | -119,000 | -10,000 | 0 | 0 |
| Net Income Growth | -53.78% | -1,090.00% | unch | unch | unch |
Minimed Group Inc (MMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
MiniMed Group Inc. is a diabetes management company. It offers technologies which includes insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies and related software and services. MiniMed Group Inc. is based in Northridge, California.
Fiscal Year End Date: 04/30